Cargando…
Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells
INTRODUCTION: Monoclonal antibodies and targeted therapies against HER2+ breast cancer has improved overall and disease-free survival in patients; however, encountering drug resistance causes recurrence, necessitating the development of newer HER2-targeted medications. A curcumin analog PGB-0-ol sho...
Autores principales: | Hermawan, Adam, Wulandari, Febri, Yudi Utomo, Rohmad, Asmah Susidarti, Ratna, Kirihata, Mitsunori, Meiyanto, Edy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652209/ https://www.ncbi.nlm.nih.gov/pubmed/38028209 http://dx.doi.org/10.1016/j.jsps.2023.101847 |
Ejemplares similares
-
Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022) -
Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
por: Susidarti, Ratna Asmah, et al.
Publicado: (2019) -
The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021) -
Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells
por: Handayani, Sri, et al.
Publicado: (2022) -
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)